Therapeutic Strategies in Huntington's Disease - Wikidata - wikimedia - TriplyDB

Therapeutic Strategies in Huntington's Disease

Therapeutic Strategies in Huntington's Disease

http://www.wikidata.org/entity/Q33790829

about

Off label use of lithium in the treatment of Huntington's disease: A case series.

P2860

Q36615521-C2373E47-EA8C-4A0B-8C44-1DD17F856BE4

P2860

Therapeutic Strategies in Huntington's Disease

http://www.wikidata.org/entity/Q33790829

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Therapeutic Strategies in Huntington's Disease

@ast

Therapeutic Strategies in Huntington's Disease

@en

type

label

Therapeutic Strategies in Huntington's Disease

@ast

Therapeutic Strategies in Huntington's Disease

@en

prefLabel

Therapeutic Strategies in Huntington's Disease

@ast

Therapeutic Strategies in Huntington's Disease

@en

P1433

Q33790829-0B00F5BD-F7AF-4645-B827-B321D100864F

P1476

Q33790829-8EB8967A-E18A-46A0-A6F5-E2537E5F3E99

P2093

Q33790829-7C0CE108-40C8-4B4D-B1C8-992654D3CE50

P2860

Q33790829-03EF9506-4A5F-4974-B0D7-D55E43968A26

Q33790829-06D67E89-008B-4E61-A81B-24090114FCB0

Q33790829-0B7F0614-3B97-401A-A3C8-E6B4F7A14B6D

Q33790829-11833AEC-57C7-46B3-9DD5-AB26B8A51F57

Q33790829-12C761A3-0992-47ED-BB56-5E2056311821

Q33790829-189DBE23-0CA8-42E7-82BF-A9E50B4A3002

Q33790829-1F2653AC-09E8-4828-89FA-AA296F48CC29

Q33790829-2464D85A-A649-41BC-A42E-0C711071D3E0

Q33790829-26690912-E22D-4B94-AE94-4FF1606F02BC

Q33790829-2844389E-0F3E-417D-9CA2-CAFFE43FA0FD

P304

Q33790829-8E7286DE-49E4-46C5-8634-9E893E26E65F

P31

Q33790829-89C2FB75-88E4-40E7-AB84-8DB909FCB41D

P356

Q33790829-AC34DA94-294C-4996-AE0A-99D21C92601E

P433

Q33790829-5C3A02A4-3337-4EC0-90CC-09212231C223

P478

Q33790829-F0EB40BB-76CF-4B8C-979B-0E03DE9E9DB6

P577

Q33790829-82C1E9BC-362C-42C6-A8AD-EC2BD1E63EF1

P5875

Q33790829-08DDF310-A2C0-4119-BF9B-2BBB1D083AA5

P698

Q33790829-9EEBFBC6-A369-4A67-82C7-EF8B21A76FD1

P921

Q33790829-08F5D368-758C-41AE-AEAA-AD0FBC06CA53

P932

Q33790829-089F5F2A-1212-455B-9FE0-37390F8DD5E4

P356

JCN.2006.2.4.213

P1433

Journal of clinical neurology

P1476

Therapeutic Strategies in Huntington's Disease

@en

P2093

Ichiro Kanazawa

http://www.w3.org/2001/XMLSchema#string

P2860

Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.

Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation

RNA interference is mediated by 21- and 22-nucleotide RNAs

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast.

RNA interference

Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

P304

213-224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3988/JCN.2006.2.4.213

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43161014

http://www.w3.org/2001/XMLSchema#string

P698

20396523

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

2854970

http://www.w3.org/2001/XMLSchema#string